Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Hyatt Hotels
H
$16.9B
| $19.6M | ﹤0.01% |
389,049
-21,293
| -5% | -$1.13M |
|
1527
Karyopharm Therapeutics
KPTI
$44.2M
| $19.6M | ﹤0.01% |
68,839
+6,617
| +11% | +$1.96M |
|
1528
iQIYI
IQ
$1.24B
| $19.5M | ﹤0.01% |
845,896
+273,890
| +48% | +$5.08M |
|
1529
Ubiquiti
UI
$34.3B
| $19.5M | ﹤0.01% |
111,723
-16,136
| -13% | -$2.71M |
|
1530
Belden
BDC
$5.05B
| $19.5M | ﹤0.01% |
598,394
+15,015
| +3% | +$500K |
|
|
RVNC
1531
DELISTED
Revance Therapeutics, Inc.
RVNC
| $19.5M | ﹤0.01% |
797,452
+73,582
| +10% | +$1.45M |
|
1532
Navient
NAVI
$892M
| $19.4M | ﹤0.01% |
2,761,354
+531,799
| +24% | +$3.96M |
|
|
XHR
1533
Xenia Hotels & Resorts
XHR
$1.82B
| $19.3M | ﹤0.01% |
2,073,926
+18,833
| +0.9% | +$175K |
|
|
GTY
1534
Getty Realty Corp
GTY
$2.06B
| $19.3M | ﹤0.01% |
651,572
+150,001
| +30% | +$3.98M |
|
1535
OSI Systems
OSIS
$3.91B
| $19.3M | ﹤0.01% |
258,261
+9,274
| +4% | +$677K |
|
1536
AerCap
AER
$24.4B
| $19.3M | ﹤0.01% |
628,360
+45,744
| +8% | +$1.31M |
|
|
CSII
1537
DELISTED
Cardiovascular Systems, Inc.
CSII
| $19.3M | ﹤0.01% |
610,255
+18,302
| +3% | +$684K |
|
1538
Knowles
KN
$3.36B
| $19.2M | ﹤0.01% |
1,257,443
+83,781
| +7% | +$1.25M |
|
1539
BILL Holdings
BILL
$4.68B
| $19.2M | ﹤0.01% |
212,639
+184,421
| +654% | +$11.9M |
|
1540
CoreCivic
CXW
$3.19B
| $19.1M | ﹤0.01% |
2,042,292
+60,700
| +3% | +$692K |
|
1541
Veracyte
VCYT
$3.71B
| $19.1M | ﹤0.01% |
737,582
+40,698
| +6% | +$1.01M |
|
|
JWN
1542
DELISTED
Nordstrom
JWN
| $19.1M | ﹤0.01% |
1,232,867
-521,864
| -30% | -$9.19M |
|
1543
HNI Corp
HNI
$3.53B
| $19.1M | ﹤0.01% |
624,579
+15,627
| +3% | +$398K |
|
1544
Towne Bank
TOWN
$3.44B
| $19.1M | ﹤0.01% |
1,011,579
+33,478
| +3% | +$621K |
|
1545
Middlesex Water
MSEX
$1.08B
| $19M | ﹤0.01% |
283,309
+13,987
| +5% | +$886K |
|
|
ICPT
1546
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $19M | ﹤0.01% |
396,462
+13,993
| +4% | +$1.08M |
|
1547
NIO
NIO
$11.5B
| $19M | ﹤0.01% |
2,472,354
+708,114
| +40% | +$3.11M |
|
1548
First Interstate BancSystem
FIBK
$3.57B
| $18.9M | ﹤0.01% |
610,802
+18,345
| +3% | +$560K |
|
|
WIRE
1549
DELISTED
Encore Wire Corp
WIRE
| $18.9M | ﹤0.01% |
386,718
+7,692
| +2% | +$353K |
|
|
MDRX
1550
DELISTED
Veradigm Inc. Common Stock
MDRX
| $18.9M | ﹤0.01% |
2,785,891
-129,222
| -4% | -$838K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.